Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.

Documenti analoghi

• Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase.
  di: Bayer, A S, et al.
  Pubblicazione: (1987)
• Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
  di: Hirano, L, et al.
  Pubblicazione: (1991)
• Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
  di: Bayer, A S, et al.
  Pubblicazione: (1988)
• Comparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamase.
  di: Knapp, C C, et al.
  Pubblicazione: (1992)
• Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.
  di: Godfrey, A J, et al.
  Pubblicazione: (1984)